- Home
- RBB vs RNAC Comparison
RBB vs RNAC Comparison
Compare RBB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBB
- RNAC
- Stock Information
- Founded
- RBB 2008
- RNAC 2007
- Country
- RBB United States
- RNAC United States
- Employees
- RBB N/A
- RNAC N/A
- Industry
- RBB Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- RBB Finance
- RNAC Health Care
- Exchange
- RBB Nasdaq
- RNAC Nasdaq
- Market Cap
- RBB 288.8M
- RNAC 282.6M
- IPO Year
- RBB 2017
- RNAC 2016
- Fundamental
- Price
- RBB $18.75
- RNAC $13.06
- Analyst Decision
- RBB Hold
- RNAC Strong Buy
- Analyst Count
- RBB 4
- RNAC 5
- Target Price
- RBB $21.25
- RNAC $40.00
- AVG Volume (30 Days)
- RBB 76.0K
- RNAC 78.5K
- Earning Date
- RBB 07-21-2025
- RNAC 08-07-2025
- Dividend Yield
- RBB 3.43%
- RNAC N/A
- EPS Growth
- RBB N/A
- RNAC N/A
- EPS
- RBB 1.17
- RNAC N/A
- Revenue
- RBB $98,305,000.00
- RNAC $34,173,000.00
- Revenue This Year
- RBB $15.58
- RNAC N/A
- Revenue Next Year
- RBB $8.35
- RNAC N/A
- P/E Ratio
- RBB $15.96
- RNAC N/A
- Revenue Growth
- RBB N/A
- RNAC 31.91
- 52 Week Low
- RBB $14.40
- RNAC $8.46
- 52 Week High
- RBB $25.30
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- RBB 65.94
- RNAC 63.45
- Support Level
- RBB $18.16
- RNAC $12.81
- Resistance Level
- RBB $18.94
- RNAC $15.57
- Average True Range (ATR)
- RBB 0.48
- RNAC 1.04
- MACD
- RBB 0.12
- RNAC 0.31
- Stochastic Oscillator
- RBB 91.67
- RNAC 56.65
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.